Detalles de la búsqueda
1.
Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy.
Mol Ther
; 26(9): 2243-2254, 2018 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30017877
2.
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy.
Int J Cancer
; 141(7): 1458-1468, 2017 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28614908
3.
Development of a Syrian hamster anti-PD-L1 monoclonal antibody enables oncolytic adenoviral immunotherapy modelling in an immunocompetent virus replication permissive setting.
Front Immunol
; 14: 1060540, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36817448
4.
Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers.
Diseases
; 10(3)2022 Aug 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35997357
5.
Adenovirus Encoding Tumor Necrosis Factor Alpha and Interleukin 2 Induces a Tertiary Lymphoid Structure Signature in Immune Checkpoint Inhibitor Refractory Head and Neck Cancer.
Front Immunol
; 13: 794251, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35355980
6.
Oncolytic Adenovirus ORCA-010 Activates Proinflammatory Myeloid Cells and Facilitates T Cell Recruitment and Activation by PD-1 Blockade in Melanoma.
Hum Gene Ther
; 32(3-4): 178-191, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33470166
7.
Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes.
Cancer Gene Ther
; 28(5): 442-454, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920593
8.
Oncolytic viruses for cancer immunotherapy.
J Hematol Oncol
; 13(1): 84, 2020 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32600470
9.
Modulation of the tumor microenvironment with an oncolytic adenovirus for effective T-cell therapy and checkpoint inhibition.
Methods Enzymol
; 635: 205-230, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32122546
10.
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity.
J Immunother Cancer
; 8(1)2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31940588
11.
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition.
Oncoimmunology
; 9(1): 1761229, 2020 05 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32923123
12.
Constitutively active GSK3ß as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppression.
Oncoimmunology
; 8(10): e1631119, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31646076
13.
CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy.
Oncoimmunology
; 7(10): e1490856, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30386680
14.
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy.
Mol Ther Oncolytics
; 4: 77-86, 2017 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28345026
Resultados
1 -
14
de 14
1
Próxima >
>>